Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes Patients During Ramadan Fasting
Background: Sulfonylureas (SUs) have been widely used in many countries for T2DM treatment. Gliclazide is one of the SUs with the lowest risk of hypoglycemia; however, the safety and effectiveness of gliclazide MR during Ramadan has not yet been reported in Indonesia. This study aimed to assess safe...
Saved in:
| Main Authors: | Soebagijo Adi Soelistijo, Andi Makbul Aman, Hendra Zufry, Agung Pranoto, Achmad Rudijanto, Mohamed Hassanien |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2022-04-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | http://www.actamedindones.org/index.php/ijim/article/view/1758 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of self glucose monitoring on glycemic control of patients with diabetes mellitus fasting during Ramadan
by: Seydahmet Akın, et al.
Published: (2022-03-01) -
The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus
by: N. A. Petunina, et al.
Published: (2024-09-01) -
Ramadan fasting and infectious diseases: a systematic review
by: Nicola Luigi Bragazzi, et al.
Published: (2015-11-01) -
Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
by: Nina A. Petunina, et al.
Published: (2020-12-01) -
Diabetes management during and after Ramadan among pregnant women in Saudi Arabia: exploring self-efficacy, self-care, and glycemic control
by: Omar Mohammed Alamri, et al.
Published: (2025-08-01)